Before you begin using a medication, be sure to inform your doctor of any medical conditions or allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use this medication.
HEALTH CANADA ADVISORY
January 21, 2013
Health Canada has issued new restrictions concerning the use of Xeomin (botulinum toxin type A). To read the full Health Canada Advisory, visit Health Canada's web site at www.hc-sc.gc.ca.
Angle-closure glaucoma: Botulinum toxin can cause angle-closure glaucoma in those who are at risk. Your doctor will monitor for this if necessary.
Distant toxin spread: Very rarely, this medication may spread to other parts of the body other than where it was injected, leading to muscle weakness, difficulty swallowing, pneumonia, speech difficulties, and breathing problems. Distant toxin spread can be fatal. If you develop severe difficulty swallowing, speaking, or breathing while using this medication, contact your doctor immediately.
Occupational hazards: Your ability to drive and use machines may be affected either because of the disease for which you are being treated, the way botulinum toxin works in your body, or the possible side effects of botulinum toxin. People using botulinum toxin should not drive a car or perform hazardous tasks until they have fully recovered from the effects of this medication.
Other medical conditions: People with amyotrophic lateral sclerosis, bleeding disorders, with disorders that produce a depletion of acetylcholine, or disorders that produce peripheral neuromuscular dysfunction should discuss with their doctor how this medication may affect their medical condition, how their medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.
Pregnancy: This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while receiving this medication, contact your doctor immediately.
Breast-feeding: It is not known if this medication passes into breast milk. If you are a breast-feeding mother and are receiving this medication, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using this medication have not been established for children under 18 years of age.